[go: up one dir, main page]

PT2062569E - Sistema de administração vaginal - Google Patents

Sistema de administração vaginal Download PDF

Info

Publication number
PT2062569E
PT2062569E PT07397043T PT07397043T PT2062569E PT 2062569 E PT2062569 E PT 2062569E PT 07397043 T PT07397043 T PT 07397043T PT 07397043 T PT07397043 T PT 07397043T PT 2062569 E PT2062569 E PT 2062569E
Authority
PT
Portugal
Prior art keywords
delivery system
core
compartment
drospirenone
vaginal delivery
Prior art date
Application number
PT07397043T
Other languages
English (en)
Inventor
Christine Talling
Hannu Nikander
Antti Keinaenen
Svante Holmberg
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of PT2062569E publication Critical patent/PT2062569E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
PT07397043T 2007-11-22 2007-11-22 Sistema de administração vaginal PT2062569E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07397043A EP2062569B1 (en) 2007-11-22 2007-11-22 Vaginal delivery system

Publications (1)

Publication Number Publication Date
PT2062569E true PT2062569E (pt) 2011-07-25

Family

ID=39273813

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07397043T PT2062569E (pt) 2007-11-22 2007-11-22 Sistema de administração vaginal

Country Status (6)

Country Link
EP (1) EP2062569B1 (pt)
AT (1) ATE508734T1 (pt)
DK (1) DK2062569T3 (pt)
ES (1) ES2365552T3 (pt)
PL (1) PL2062569T3 (pt)
PT (1) PT2062569E (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
SG11201805112WA (en) * 2015-12-21 2018-07-30 Bayer Oy A method of manufacturing a vaginal ring
CN110585246B (zh) * 2019-09-22 2020-06-02 深圳市多微生保健食品有限公司 一种阴道抑菌制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
DE69616551T2 (de) * 1995-07-04 2002-05-29 Akzo Nobel N.V., Arnheim/Arnhem Ringförmige vorrichtung
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
RU2302883C2 (ru) * 2001-08-31 2007-07-20 Шеринг Ой Система доставки лекарств
CA2523859C (en) * 2003-04-29 2011-08-02 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
ATE434433T1 (de) * 2004-03-24 2009-07-15 Organon Nv Arzneimittelabgabesystem auf basis von polyethylen-vinylacetat-copolymeren
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use

Also Published As

Publication number Publication date
PL2062569T3 (pl) 2011-10-31
EP2062569A1 (en) 2009-05-27
EP2062569B1 (en) 2011-05-11
ES2365552T3 (es) 2011-10-06
DK2062569T3 (da) 2011-08-29
ATE508734T1 (de) 2011-05-15

Similar Documents

Publication Publication Date Title
MX2010003656A (es) Sistema de administracion vaginal.
WO2009009688A9 (en) Delivery system
WO2006084164A3 (en) Gastric retention and controlled release delivery system
WO2006127618A3 (en) Compressible gum based delivery systems for the release of ingredients
ZA200701263B (en) Controlled release delivery system for bioo-active agents
TW200745149A (en) Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
WO2008051942A3 (en) Farnesoid x receptor agonists
AR048185A1 (es) Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico
TW200740787A (en) (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones
WO2007076260A3 (en) Farnesoid x receptor agonists
WO2006010097A3 (en) Sustained release compositions containing progesterone receptor modulators
EP1357870A4 (en) BIOADHESIVE FOAM FILTER WITH FIXED RELEASE
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
IL179846A (en) A system for administering drugs that include a core and a membrane that contains a regulating factor and a method for its use
HK1110221A1 (en) Use of prodrugs for ocular intravitreous administration
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
IL184448A0 (en) Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
PT2062569E (pt) Sistema de administração vaginal
WO2008089488A3 (en) Biodegradable intravaginal devices for delivery of therapeutics
EP2037663A4 (en) PROCESS, SYSTEM AND DEVICE FOR SAVING AND PLAYING POC MEETINGS
AR076588A1 (es) Sistema de liberacion vaginal
PT2190431E (pt) Composições compreendendo um agonista do recetor dos glucocorticoides dissociados para tratamento ou controlo de inflamação do segmento anterior
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2004012664A3 (en) Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity